For better or worse, a security firm’s attempt to cash in on software bugs -- by shorting a company’s stock and then publicizing the flaws -- might have pioneered a new approach to vulnerability disclosure. Last August, security company …
and reiterated its short position on STJ stock. And while call volume has caught on fire in ABT's options pits, it looks like one trader is using calls to set a short-term ceiling on the stock. At last check, roughly 13,000 ABT calls were on the …
Muddy Waters, the firm founded by noted short-seller Carson Block, is short St. Jude Medical Inc. The stock is down almost 7% on the news. The firm says it's shorting St. Jude because its pacemakers are faulty and susceptible to …
Shares of St. Jude Medical are up about 5 percent this morning on news of strong sales during the company’s second quarter. The Little Canada-based medical device company saw revenue increase by 14 percent to $947 million during …
Nonetheless, shares of St. Jude are still up by nearly 4%, as investors perhaps feel Abbott Laboratories is just playing …
The biggest medical device company still headquartered in Minnesota, St. Jude Medical, will be whisked away to the Chicago suburbs under a $25 billion cash-and-stock acquisition by Abbott Laboratories announced Thursday. The …
The two firms had a financial incentive in releasing the report: Muddy Waters had “shorted” St. Jude stock (i.e., bet that it would decline in value), and MedSec had arranged to share any profits. St. Jude’s stock price has indeed taken a …
Shares of St. Jude Medical Inc. (NYSE:STJ) hit a 52-week high in mid-day trading on Wall Street on Tuesday, with investors basking in the glow of a bullish recommendation from a JP Morgan analyst on the company’s new Quadra …
Rather than disclose the security vulnerabilities to the manufacturer directly, the medical device maker says that MedSec turned to Muddy Waters in order to make some money on St. Jude stock after prices plummeted due to the report. …